TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Performant Healthcare ( (PHLT) ) has provided an update.
On October 17, 2025, Performant Healthcare‘s stockholders approved a merger agreement with Continental Buyer, Inc. and Prevail Merger Sub, Inc., resulting in Performant becoming a wholly-owned subsidiary of Continental Buyer. The approval also included a non-binding advisory vote on executive compensation related to the merger and the possibility to adjourn the meeting if necessary. The merger is expected to impact Performant’s operations by integrating it into Continental Buyer’s corporate structure, potentially affecting stakeholders and market positioning.
The most recent analyst rating on (PHLT) stock is a Hold with a $8.00 price target. To see the full list of analyst forecasts on Performant Healthcare stock, see the PHLT Stock Forecast page.
Spark’s Take on PHLT Stock
According to Spark, TipRanks’ AI Analyst, PHLT is a Neutral.
Performant Healthcare’s stock score is primarily impacted by its financial performance challenges, including inconsistent profitability and cash flow issues. While technical analysis shows positive momentum, the valuation remains weak due to significant losses and no dividend yield.
To see Spark’s full report on PHLT stock, click here.
More about Performant Healthcare
Average Trading Volume: 1,323,926
Technical Sentiment Signal: Buy
Current Market Cap: $621.8M
See more insights into PHLT stock on TipRanks’ Stock Analysis page.